MedTrace Logo

Benefits of Nutritional Ingredients for Type 2 Diabetes

NCT06327711 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-12-04

No results posted yet for this study

Summary

This is a prospective randomized, double-blinded, parallel design study to evaluate the benefits of long-term consumption of two experimental blends of liquid supplements.

Conditions

  • Diabetes type2

Interventions

OTHER

Control: CHO Blend

2 servings as a snack or between meals morning and evening

OTHER

Experimental: CHO Blend plus AN100

2 servings as a snack or between meals morning and evening

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Suzette Pereira · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06327711 on ClinicalTrials.gov